Core Viewpoint - The stock of HeartTech Medical (02291) has dropped over 10% following the announcement of a significant share sale by its major shareholder Lepu Medical [1] Group 1: Stock Performance - HeartTech Medical's stock fell by 10.78%, trading at 24.5 HKD with a transaction volume of 283 million HKD [1] Group 2: Shareholder Activity - Lepu Medical sold a total of 11.14 million H-shares at a price of 22.79 HKD per share, representing approximately 3.21% of the total issued shares as of the announcement date [1] - Post-sale, Lepu Medical retains 268.86 million shares, which includes 266.06 million shares directly held and 2.8 million shares held by its subsidiary, accounting for about 77.54% of the total issued share capital [1] - The announcement emphasized Lepu Medical's confidence in the business operations of HeartTech Medical, stating that the sale was intended to enhance the liquidity of the company's stock [1]